DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
160 hedge funds and large institutions have $1.34B invested in DIPLOMAT PHARMACY, INC. in 2016 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 62 increasing their positions, 47 reducing their positions, and 26 closing their positions.
38% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 26
32% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 47
12% more call options, than puts
Call options by funds: $2.7M | Put options by funds: $2.4M
6% more funds holding
Funds holding: 151 → 160 (+9)
19% less capital invested
Capital invested by funds: $1.66B → $1.34B (-$323M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$39M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$34.6M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$32.6M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$23.7M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$41.2M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$38.2M |
| 3 |
BAMCO Inc
New York
|
-$27.8M |
| 4 |
Millennium Management
New York
|
-$24.3M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$15.6M |
DPLO Hedge Fund Activity: Q1 2016 in Review
160 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2016, worth a combined $1.34B — down 19% from $1.66B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new DPLO positions and 26 closed out — a net gain of 10 holders — while 62 added to existing stakes and 47 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $39M. The largest seller was Next Century Growth Investors, exiting entirely with an estimated $41.2M sold.
- 160 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2016, up from 151 in Q4 2015.
- Funds reported $1.34B of DIPLOMAT PHARMACY, INC. stock for Q1 2016, down 19% quarter-over-quarter.
- 36 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2016 and 26 closed out, a net change of +10 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2016 was BlackRock Fund Advisors, an estimated $39M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q1 2016 was Next Century Growth Investors, an estimated $41.2M sold.
Based on aggregated 13F filings for Q1 2016.